ACUTE EFFECTS OF EXERCISE ON POST-PRANDIAL ACTIVITY OF DIPEPTIDYL PEPTIDASE-4 IN TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Sousa, N. M. [1 ]
Silva, L. R. [1 ]
Barros, F. C. [1 ]
Fraga, M. Z. [1 ]
Coelho, B. [2 ]
Silva Filho, W. G. [2 ]
Barauna, V. G. [2 ]
机构：
[1] Fac Estacio Sa, Lab Exercise Physiol, Vitoria, ES, Brazil
[2] Univ Fed Espirito Santo, Lab Mol & Cellular Physiol, Vitoria, ES, Brazil
来源：
CARDIOLOGY | 2017年 / 137卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
308
引用
收藏
页码：321 / 321
页数：1
相关论文
共 50 条
  • [31] Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
    Yagi, Shusuke
    Aihara, Ken-ichi
    Akaike, Masashi
    Fukuda, Daiju
    Salim, Hotimah Masdan
    Ishida, Masayoshi
    Matsuura, Tomomi
    Ise, Takayuki
    Yamaguchi, Koji
    Iwase, Takashi
    Yamada, Hirotsugu
    Soeki, Takeshi
    Wakatsuki, Tetsuzo
    Shimabukuro, Michio
    Matsumoto, Toshio
    Sata, Masataka
    DIABETES & METABOLISM JOURNAL, 2015, 39 (04) : 342 - 347
  • [32] Potential Impact of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Pathophysiology in Type 2 Diabetes Mellitus
    Davidson, Michael H.
    POSTGRADUATE MEDICINE, 2014, 126 (03) : 56 - 65
  • [33] Association between dipeptidyl peptidase-4 inhibitors use and leptin in type 2 diabetes mellitus
    Xin Wei
    Yu Bai
    Zhuo Wang
    Xiaohong Zheng
    Zening Jin
    Xin Liu
    Diabetology & Metabolic Syndrome, 13
  • [34] Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus
    Li, Ning
    Wang, Li-Jun
    Jiang, Bo
    Li, Xiang-qian
    Guo, Chuan-long
    Guo, Shu-ju
    Shi, Da-Yong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 151 : 145 - 157
  • [35] EFFECT OF THE DIPEPTIDYL PEPTIDASE-4 INHIBITOR SITAGLIPTIN IN OLDER ADULTS WITH TYPE 2 DIABETES MELLITUS
    Stafford, Sara
    Elahi, Dariush
    Meneilly, Graydon S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (06) : 1148 - 1149
  • [36] The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
    Susana Ravassa
    Joaquín Barba
    Isabel Coma-Canella
    Ana Huerta
    Begoña López
    Arantxa González
    Javier Díez
    Cardiovascular Diabetology, 12
  • [37] The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
    Ravassa, Susana
    Barba, Joaquin
    Coma-Canella, Isabel
    Huerta, Ana
    Lopez, Begona
    Gonzalez, Arantxa
    Diez, Javier
    CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [38] Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes
    Mega, Cristina
    Teixeira-Lemos, Edite
    Fernandes, Rosa
    Reis, Flavio
    JOURNAL OF DIABETES RESEARCH, 2017, 2017
  • [39] Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
    Jinsong Geng
    Hao Yu
    Yiwei Mao
    Peng Zhang
    Yingyao Chen
    PharmacoEconomics, 2015, 33 : 581 - 597
  • [40] Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
    Mkele, Gail
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2015, 20 (01) : 64 - 66
12345